Interferon in the treatment of cutaneous T-cell lymphoma.
Journal Article (Journal Article;Review)
All of the recombinant interferons are active agents for the systemic treatment of mycosis fungoides and Sézary syndrome. The response rates are similar to those observed with systemic chemotherapy. There is no clear evidence that combining interferons with other systemic therapies increases the response rates. The combination of interferon with PUVA provides provocative results. The optimal role of interferons in the treatment of mycosis fungoides and Sézary's syndrome is undefined.
- Olsen, EA; Bunn, PA
- October 1995
Volume / Issue
- 9 / 5
Start / End Page
- 1089 - 1107
International Standard Serial Number (ISSN)
- United States